Species
|
Resource
|
RRC ID
|
Title
|
Journal
|
Published
|
Link
|
Human and Animal Cells
|
TGBC2TKB(RCB1130)
,
TGBC14TKB(RCB1186)
,
TGBC24TKB(RCB1196)
,
TGBC18TKB(RCB1169)
,
TGBC50TKB(RCB1280)
,
TGBC51TKB(RCB1281)
,
TGBC52TKB(RCB1282)
|
59664
|
Molecular targeting of HER2-overexpressing biliary tract cancer cells with trastuzumab emtansine, an antibody-cytotoxic drug conjugate.
|
Cancer Chemother Pharmacol |
2019-4-1 |
Pubmed
Full text
|
Human and Animal Cells
|
HuCCT1(RCB1960)
,
TFK-1(RCB2537)
|
56026
|
Jab1 Silencing Inhibits Proliferation and Sensitizes to Cisplatin in Biliary Tract Cancer.
|
Cancer Res Treat |
2019-7-1 |
Pubmed
Full text
|
Human and Animal Cells
|
HuCCT1(RCB1960)
,
TFK-1(RCB2537)
|
56025
|
Therapeutic Targeting of the DNA Damage Response Using an ATR Inhibitor in Biliary Tract Cancer.
|
Cancer Res Treat |
2019-7-1 |
Pubmed
Full text
|
Human and Animal Cells
|
HuCCT1(RCB1960)
|
54783
|
Human equilibrative nucleoside transporter 1 (hENT1) expression as a predictive biomarker for gemcitabine chemotherapy in biliary tract cancer.
|
PLoS One |
2018-12-17 |
Pubmed
Full text
|
Human and Animal Cells
|
TGBC1TKB(RCB1129)
|
45402
|
Anti-cancer effect and gene modulation of ET-743 in human biliary tract carcinoma preclinical models.
|
BMC Cancer |
2014-12-5 |
Pubmed
Full text
|
Human and Animal Cells
|
YSCCC(RCB1549)
,
TGBC1TKB(RCB1129)
,
TGBC2TKB(RCB1130)
,
TGBC14TKB(RCB1186)
|
45226
|
Overexpression and gene amplification of EGFR, HER2, and HER3 in biliary tract carcinomas, and the possibility for therapy with the HER2-targeting antibody pertuzumab.
|
J Gastroenterol |
2015-4-1 |
Pubmed
Full text
|
Human and Animal Cells
|
TGBC1TKB(RCB1129)
,
TGBC2TKB(RCB1130)
,
PANC-1(RCB2095)
,
PK-1(RCB1972)
,
PK-45P(RCB2141)
,
PK-59(RCB1901)
|
44372
|
Cancer detection by ubiquitin carboxyl-terminal esterase L1 methylation in pancreatobiliary fluids.
|
World J Gastroenterol |
2013-3-21 |
Pubmed
Full text
|
Human and Animal Cells
|
HuH-28(RCB1943)
,
TGBC1TKB(RCB1129)
|
43755
|
Antitumor activity of Src inhibitor saracatinib (AZD-0530) in preclinical models of biliary tract carcinomas.
|
Mol Cancer Ther |
2012-7-1 |
Pubmed
Full text
|
Human and Animal Cells
|
SSP-25(RCB1293)
,
RBE(RCB1292)
,
TKKK(RCB1907)
,
TGBC2TKBRCB1130)
,
TGBC14TKB(RCB1186)
,
TGBC24TKB(RCB1196)
,
293(RCB1637)
|
43435
|
Genetic alteration of Keap1 confers constitutive Nrf2 activation and resistance to chemotherapy in gallbladder cancer.
|
Gastroenterology |
2008-10-1 |
Pubmed
Full text
|
Human and Animal Cells
|
TGBC2TKB(RCB1130)
|
42710
|
Correlation between expression of major histocompatibility complex class I and that of antigen presenting machineries in carcinoma cell lines of the pancreas, biliary tract and colon.
|
Kobe J Med Sci |
2006-1-1 |
Pubmed
|
Human and Animal Cells
|
TGBC1TKB(RCB1129)
|
38244
|
Targeting EGFR/HER2 pathways enhances the antiproliferative effect of gemcitabine in biliary tract and gallbladder carcinomas.
|
BMC Cancer |
2010-11-18 |
Pubmed
Full text
|
Human and Animal Cells
|
TGBC1TKB(RCB1129)
,
TGBC2TKB(RCB1130)
,
TGBC14TKB(RCB1186)
,
TKKK(RCB1907)
|
37807
|
Overexpression of beta3/gamma2 chains of laminin-5 and MMP7 in biliary cancer.
|
World J Gastroenterol |
2009-8-21 |
Pubmed
Full text
|
Human and Animal Cells
|
Hep G2(RCB0459)
,
HuH-7(RCB1366)
|
18102
|
EpCAM- and EGFR-targeted selective gene therapy for biliary cancers using Z33-fiber-modified adenovirus.
|
Int J Cancer |
2011-9-1 |
Pubmed
Full text
|